Chemical probes targeting epigenetic proteins: Applications beyond oncology

References

• Arrowsmith CH, Audia JE, Austin C, Baell J, Bennett J, Blagg J, Bountra C, Brennan PE, Brown PJ, Bunnage ME, et al. The promise and peril of chemical probes. Nat Chem Biol 2015; 11:536-41; PMID:26196764; https://doi.org/10.1038/nchembio.1867
   PubMed Web of Science ®Google Scholar
• Brown PJ, Muller S. Open access chemical probes for epigenetic targets. Future Med Chem 2015; 7:1901-17; PMID:26397018; https://doi.org/10.4155/fmc.15.127
   PubMed Web of Science ®Google Scholar
• Bunnage ME. Getting pharmaceutical R&D back on target. Nat Chem Biol 2011; 7:335-9; PMID:21587251; https://doi.org/10.1038/nchembio.581
   PubMed Web of Science ®Google Scholar
• Frye SV. The art of the chemical probe. Nat Chem Biol 2010; 6:159-61; PMID:20154659; https://doi.org/10.1038/nchembio.296
   PubMed Web of Science ®Google Scholar
• Muller S, Brown PJ. Epigenetic chemical probes. Clin Pharmacol Therap 2012; 92:689-93; PMID:23093316; https://doi.org/10.1038/clpt.2012.154
   PubMed Web of Science ®Google Scholar
• Bamborough P, Chung CW, Demont EH, Furze RC, Bannister AJ, Che KH, Diallo H, Douault C, Grandi P, Kouzarides T, et al. A chemical probe for the ATAD2 bromodomain. Angewandte Chemie 2016; 55:11382-6; PMID:27530368; https://doi.org/10.1002/anie.201603928
   PubMedGoogle Scholar
• Lu J, Qian Y, Altieri M, Dong H, Wang J, Raina K, Hines J, Winkler JD, Crew AP, Coleman K, et al. Hijacking the E3 Ubiquitin Ligase cereblon to efficiently target BRD4. Chem Biol 2015; 22:755-63; PMID:26051217; https://doi.org/10.1016/j.chembiol.2015.05.009
   PubMedGoogle Scholar
• Mitchell LH, Drew AE, Ribich SA, Rioux N, Swinger KK, Jacques SL, Lingaraj T, Boriack-Sjodin PA, Waters NJ, Wigle TJ, et al. Aryl pyrazoles as potent inhibitors of arginine Methyltransferases: identification of the first PRMT6 tool compound. Acs Med Chem Lett 2015; 6:655-9; PMID:26101569; https://doi.org/10.1021/acsmedchemlett.5b00071
   PubMed Web of Science ®Google Scholar
• Winter GE, Buckley DL, Paulk J, Roberts JM, Souza A, Dhe-Paganon S, Bradner JE. DRUG DEVELOPMENT. Phthalimide conjugation as a strategy for in vivo target protein degradation. Science 2015; 348:1376-81; PMID:25999370; https://doi.org/10.1126/science.aab1433
   PubMed Web of Science ®Google Scholar
• Filippakopoulos P, Picaud S, Mangos M, Keates T, Lambert JP, Barsyte-Lovejoy D, Felletar I, Volkmer R, Müller S, Pawson T, et al. Histone recognition and large-scale structural analysis of the human bromodomain family. Cell 2012; 149:214-31; PMID:22464331; https://doi.org/10.1016/j.cell.2012.02.013
   PubMed Web of Science ®Google Scholar
• Flynn EM, Huang OW, Poy F, Oppikofer M, Bellon SF, Tang Y, Cochran AG. A Subset of Human bromodomains recognizes butyryllysine and crotonyllysine histone peptide modifications. Structure 2015; 23:1801-14; PMID:26365797; https://doi.org/10.1016/j.str.2015.08.004
   PubMed Web of Science ®Google Scholar
• Di Costanzo A, Del Gaudio N, Migliaccio A, Altucci L. Epigenetic drugs against cancer: an evolving landscape. Arch Toxicol 2014; 88:1651-68; PMID:25085708; https://doi.org/10.1007/s00204-014-1315-6
   PubMed Web of Science ®Google Scholar
• Filippakopoulos P, Knapp S. Targeting bromodomains: epigenetic readers of lysine acetylation. Nat Rev Drug Dis 2014; 13:337-56; PMID:24751816; https://doi.org/10.1038/nrd4286
   PubMed Web of Science ®Google Scholar
• Wadhwa E, Nicolaides T. Bromodomain Inhibitor Review: Bromodomain and Extra-terminal family protein inhibitors as a potential new therapy in central nervous system tumors. Cureus 2016; 8:e620; PMID:27382528; https://doi.org/10.7759/cureus.620
   PubMedGoogle Scholar
• Ghoshal A, Yugandhar D, Srivastava AK. BET inhibitors in cancer therapeutics: a patent review. Exp Opin Therap Patents 2016; 26:505-22; PMID:26924192; https://doi.org/10.1517/13543776.2016.1159299
   PubMed Web of Science ®Google Scholar
• Chaidos A, Caputo V, Karadimitris A. Inhibition of bromodomain and extra-terminal proteins (BET) as a potential therapeutic approach in haematological malignancies: emerging preclinical and clinical evidence. Therap Adv Hematol 2015; 6:128-41; PMID:26137204; https://doi.org/10.1177/2040620715576662
   PubMed Web of Science ®Google Scholar
• Jung M, Gelato KA, Fernandez-Montalvan A, Siegel S, Haendler B. Targeting BET bromodomains for cancer treatment. Epigenomics 2015; 7:487-501; PMID:26077433; https://doi.org/10.2217/epi.14.91
   PubMed Web of Science ®Google Scholar
• Fu LL, Tian M, Li X, Li JJ, Huang J, Ouyang L, Zhang Y, Liu B. Inhibition of BET bromodomains as a therapeutic strategy for cancer drug discovery. Oncotarget 2015; 6:5501-16; PMID:25849938; https://doi.org/10.18632/oncotarget.3551
   PubMed Web of Science ®Google Scholar
• Shi J, Vakoc CR. The mechanisms behind the therapeutic activity of BET bromodomain inhibition. Mol Cell 2014; 54:728-36; PMID:24905006; https://doi.org/10.1016/j.molcel.2014.05.016
   PubMed Web of Science ®Google Scholar
• Lochrin SE, Price DK, Figg WD. BET bromodomain inhibitors–a novel epigenetic approach in castration-resistant prostate cancer. Cancer Biol Ther 2014; 15:1583-5; PMID:25535892; https://doi.org/10.4161/15384047.2014.962297
   PubMed Web of Science ®Google Scholar
• Sahai V, Redig AJ, Collier KA, Eckerdt FD, Munshi HG. Targeting bet bromodomain proteins in solid tumors. Oncotarget 2016; 7(33):53997-4009; PMID:27283767; https://doi.org/10.18632/oncotarget.9804
   PubMed Web of Science ®Google Scholar
• Hamamoto R, Nakamura Y. Dysregulation of protein methyltransferases in human cancer: An emerging target class for anticancer therapy. Cancer Sci 2016; 107:377-84; PMID:26751963; https://doi.org/10.1111/cas.12884
   PubMed Web of Science ®Google Scholar
• Hirsch CL, Wrana JL, Dent SY. KATapulting toward pluripotency and cancer. J Mol Biol 2016; PMID:27720985; https://doi.org/10.1016/j.jmb.2016.09.023
   PubMedGoogle Scholar
• Arcipowski KM, Martinez CA, Ntziachristos P. Histone demethylases in physiology and cancer: a tale of two enzymes, JMJD3 and UTX. Curr Opin Genet Dev 2016; 36:59-67; PMID:27151432; https://doi.org/10.1016/j.gde.2016.03.010
   PubMed Web of Science ®Google Scholar
• Muller S. Targeting the Bromome: are we there yet? Future Med Chem 2016; 8:1529-32; PMID:27578167; https://doi.org/10.4155/fmc-2016-0136
   PubMed Web of Science ®Google Scholar
• Diamant G, Dikstein R. Transcriptional control by NF-kappaB: elongation in focus. Biochim Et Biophys Acta 2013; 1829:937-45; PMID:23624258; https://doi.org/10.1016/j.bbagrm.2013.04.007
   PubMed Web of Science ®Google Scholar
• Choi CS, Hong SH, Sim S, Cho KS, Kim JW, Yang SM, Jeon SJ, You JS, Shin CY. The epigenetic reader BRD2 as a specific modulator of PAI-1 expression in lipopolysaccharide-stimulated mouse primary astrocytes. Neurochem Res 2015; 40:2211-9; PMID:26349765; https://doi.org/10.1007/s11064-015-1710-2
   PubMed Web of Science ®Google Scholar
• Alsarraj J, Faraji F, Geiger TR, Mattaini KR, Williams M, Wu J, Ha NH, Merlino T, Walker RC, Bosley AD, et al. BRD4 short isoform interacts with RRP1B, SIPA1 and components of the LINC complex at the inner face of the nuclear membrane. PloS One 2013; 8:e80746; PMID:24260471; https://doi.org/10.1371/journal.pone.0080746
   PubMed Web of Science ®Google Scholar
• Wu SY, Lee AY, Lai HT, Zhang H, Chiang CM. Phospho switch triggers Brd4 chromatin binding and activator recruitment for gene-specific targeting. Mol Cell 2013; 49:843-57; PMID:23317504; https://doi.org/10.1016/j.molcel.2012.12.006
   PubMed Web of Science ®Google Scholar
• Zou Z, Huang B, Wu X, Zhang H, Qi J, Bradner J, Nair S, Chen LF. Brd4 maintains constitutively active NF-kappaB in cancer cells by binding to acetylated RelA. Oncogene 2014; 33:2395-404; PMID:23686307; https://doi.org/10.1038/onc.2013.179
   PubMed Web of Science ®Google Scholar
• Suarez-Alvarez B, Morgado-Pascual JL, Rayego-Mateos S, Rodriguez RM, Rodrigues-Diez R, Cannata-Ortiz P, Sanz AB, Egido J, Tharaux PL, Ortiz A, et al. Inhibition of bromodomain and extraterminal domain family proteins ameliorates experimental renal damage. J Am Soc Nephrol 2016; PMID:27436852; https://doi.org/10.1681/ASN.2015080910
   PubMed Web of Science ®Google Scholar
• Brown JD, Lin CY, Duan Q, Griffin G, Federation AJ, Paranal RM, Bair S, Newton G, Lichtman AH, Kung AL, et al. NF-kappaB directs dynamic super enhancer formation in inflammation and atherogenesis. Mol Cell 2014; 56:219-31; PMID:25263595; https://doi.org/10.1016/j.molcel.2014.08.024
   PubMed Web of Science ®Google Scholar
• Duan Q, Mao X, Xiao Y, Liu Z, Wang Y, Zhou H, Zhou Z, Cai J, Xia K, Zhu Q, et al. Super enhancers at the miR-146a and miR-155 genes contribute to self-regulation of inflammation. Biochim Et Biophy Acta 2016; 1859:564-71; PMID:26855180; https://doi.org/10.1016/j.bbagrm.2016.02.004
   PubMedGoogle Scholar
• Yang Z, Yik JH, Chen R, He N, Jang MK, Ozato K, Zhou Q. Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4. Mol Cell 2005; 19:535-45; PMID:16109377; https://doi.org/10.1016/j.molcel.2005.06.029
   PubMed Web of Science ®Google Scholar
• Loven J, Hoke HA, Lin CY, Lau A, Orlando DA, Vakoc CR, Bradner JE, Lee TI, Young RA. Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell 2013; 153:320-34; PMID:23582323; https://doi.org/10.1016/j.cell.2013.03.036
   PubMed Web of Science ®Google Scholar
• Yoshida H, Bansal K, Schaefer U, Chapman T, Rioja I, Proekt I, Anderson MS, Prinjha RK, Tarakhovsky A, Benoist C, et al. Brd4 bridges the transcriptional regulators, Aire and P-TEFb, to promote elongation of peripheral-tissue antigen transcripts in thymic stromal cells. Proc Nat Acad Sci U S A 2015; 112:E4448-57; PMID:26216992; https://doi.org/10.1073/pnas.1512081112
   PubMed Web of Science ®Google Scholar
• Ghari F, Quirke AM, Munro S, Kawalkowska J, Picaud S, McGouran J, Subramanian V, Muth A, Williams R, Kessler B, et al. Citrullination-acetylation interplay guides E2F-1 activity during the inflammatory response. Sci Adv 2016; 2:e1501257; PMID:26989780
   PubMed Web of Science ®Google Scholar
• Nicodeme E, Jeffrey KL, Schaefer U, Beinke S, Dewell S, Chung CW, Chandwani R, Marazzi I, Wilson P, Coste H, et al. Suppression of inflammation by a synthetic histone mimic. Nature 2010; 468:1119-23; PMID:21068722; https://doi.org/10.1038/nature09589
   PubMed Web of Science ®Google Scholar
• Ferri E, Petosa C, McKenna CE. Bromodomains: Structure, function and pharmacology of inhibition. Biochem Pharmacol 2016; 106:1-18; PMID:26707800; https://doi.org/10.1016/j.bcp.2015.12.005
   PubMed Web of Science ®Google Scholar
• Zhang QG, Qian J, Zhu YC. Targeting bromodomain-containing protein 4 (BRD4) benefits rheumatoid arthritis. Immunol Lett 2015; 166:103-8; PMID:26093279; https://doi.org/10.1016/j.imlet.2015.05.016
   PubMed Web of Science ®Google Scholar
• Xiao Y, Liang L, Huang M, Qiu Q, Zeng S, Shi M, Zou Y, Ye Y, Yang X, Xu H. Bromodomain and extra-terminal domain bromodomain inhibition prevents synovial inflammation via blocking IkappaB kinase-dependent NF-kappaB activation in rheumatoid fibroblast-like synoviocytes. Rheumatology 2016; 55:173-84; PMID:26324948; https://doi.org/10.1093/rheumatology/kev312
   PubMed Web of Science ®Google Scholar
• Meng S, Zhang L, Tang Y, Tu Q, Zheng L, Yu L, Murray D, Cheng J, Kim SH, Zhou X, et al. BET inhibitor JQ1 blocks inflammation and bone destruction. J Dental Res 2014; 93:657-62; PMID:24799421; https://doi.org/10.1177/0022034514534261
   PubMed Web of Science ®Google Scholar
• Baud'huin M, Lamoureux F, Jacques C, Rodriguez Calleja L, Quillard T, Charrier C, Amiaud J, Berreur M, Brounais-LeRoyer B, Owen R, et al. Inhibition of BET proteins and epigenetic signaling as a potential treatment for osteoporosis. Bone 2016; 94:10-21; PMID:27669656; https://doi.org/10.1016/j.bone.2016.09.020
   PubMed Web of Science ®Google Scholar
• Bandukwala HS, Gagnon J, Togher S, Greenbaum JA, Lamperti ED, Parr NJ, Molesworth AM, Smithers N, Lee K, Witherington J, et al. Selective inhibition of CD4+ T-cell cytokine production and autoimmunity by BET protein and c-Myc inhibitors. Proc Natl Acad Sci USA 2012; 109:14532-7; PMID:22912406; https://doi.org/10.1073/pnas.1212264109
   PubMed Web of Science ®Google Scholar
• Mele DA, Salmeron A, Ghosh S, Huang HR, Bryant BM, Lora JM. BET bromodomain inhibition suppresses TH17-mediated pathology. J Exp Med 2013; 210:2181-90; PMID:24101376; https://doi.org/10.1084/jem.20130376
   PubMed Web of Science ®Google Scholar
• Kagoya Y, Nakatsugawa M, Yamashita Y, Ochi T, Guo T, Anczurowski M, Saso K, Butler MO, Arrowsmith CH, Hirano N. BET bromodomain inhibition enhances T cell persistence and function in adoptive immunotherapy models. J Clin Invest 2016; 126:3479-94; PMID:27548527; https://doi.org/10.1172/JCI86437
   PubMed Web of Science ®Google Scholar
• Toniolo PA, Liu S, Yeh JE, Moraes-Vieira PM, Walker SR, Vafaizadeh V, Barbuto JA, Frank DA. Inhibiting STAT5 by the BET bromodomain inhibitor JQ1 disrupts human dendritic cell maturation. J Immunol 2015; 194:3180-90; PMID:25725100; https://doi.org/10.4049/jimmunol.1401635
   PubMed Web of Science ®Google Scholar
• Sun Y, Wang Y, Toubai T, Oravecz-Wilson K, Liu C, Mathewson N, Wu J, Rossi C, Cummings E, Wu D, et al. BET bromodomain inhibition suppresses graft-versus-host disease after allogeneic bone marrow transplantation in mice. Blood 2015; 125:2724-8; PMID:25778533; https://doi.org/10.1182/blood-2014-08-598037
   PubMed Web of Science ®Google Scholar
• Clifford RL, Patel JK, John AE, Tatler AL, Mazengarb L, Brightling CE, Knox AJ. CXCL8 histone H3 acetylation is dysfunctional in airway smooth muscle in asthma: regulation by BET. Am J Physiol Lung Cell Mol Physiol 2015; 308:L962-72; PMID:25713319; https://doi.org/10.1152/ajplung.00021.2015
   PubMed Web of Science ®Google Scholar
• Kokkola T, Suuronen T, Pesonen M, Filippakopoulos P, Salminen A, Jarho EM, Lahtela-Kakkonen M. BET inhibition upregulates SIRT1 and Alleviates inflammatory responses. Chembioch Eur J Chem Biol 2015; 16:1997-2001; PMID:26212199; https://doi.org/10.1002/cbic.201500272
   PubMed Web of Science ®Google Scholar
• Tang X, Peng R, Phillips JE, Deguzman J, Ren Y, Apparsundaram S, Luo Q, Bauer CM, Fuentes ME, DeMartino JA, et al. Assessment of Brd4 inhibition in idiopathic pulmonary fibrosis lung fibroblasts and in vivo models of lung fibrosis. Am J Pathol 2013; 183:470-79; PMID:23759512; https://doi.org/10.1016/j.ajpath.2013.04.020
   PubMed Web of Science ®Google Scholar
• Nadeem A, Al-Harbi NO, Al-Harbi MM, El-Sherbeeny AM, Ahmad SF, Siddiqui N, Ansari MA, Zoheir KM, Attia SM, Al-Hosaini KA, et al. Imiquimod-induced psoriasis-like skin inflammation is suppressed by BET bromodomain inhibitor in mice through RORC/IL-17A pathway modulation. Pharmacological Research 2015; 99:248-57; PMID:26149470; https://doi.org/10.1016/j.phrs.2015.06.001
   PubMed Web of Science ®Google Scholar
• Chen K, Campfield BT, Wenzel SE, McAleer JP, Kreindler JL, Kurland G, Gopal R, Wang T, Chen W, Eddens T, et al. Antiinflammatory effects of bromodomain and extraterminal domain inhibition in cystic fibrosis lung inflammation. JCI insight 2016; 1(11)e87168; PMID:27517095; https://doi.org/10.1172/jci.insight.87168
   Web of Science ®Google Scholar
• Peeters JG, Vervoort SJ, Tan SC, Mijnheer G, de Roock S, Vastert SJ, Nieuwenhuis EE, van Wijk F, Prakken BJ, Creyghton MP, et al. Inhibition of super-enhancer activity in autoinflammatory site-derived T Cells reduces disease-associated gene expression. Cell Rep 2015; 12:1986-96; PMID:26387944; https://doi.org/10.1016/j.celrep.2015.08.046
   PubMed Web of Science ®Google Scholar
• Wei S, Sun Y, Sha H. Therapeutic targeting of BET protein BRD4 delays murine lupus. Inter Immunopharmacol 2015; 29:314-9; PMID:26590112; https://doi.org/10.1016/j.intimp.2015.10.036
   PubMed Web of Science ®Google Scholar
• Mahdi H, Fisher BA, Källberg H, Plant D, Malmström V, Rönnelid J, Charles P, Ding B, Alfredsson L, Padyukov L, et al. Specific interaction between genotype, smoking and autoimmunity to citrullinated alpha-enolase in the etiology of rheumatoid arthritis. Nat Gen 2009; 41:1319-24; PMID:19898480; https://doi.org/10.1038/ng.480
   PubMed Web of Science ®Google Scholar
• Belkina AC, Nikolajczyk BS, Denis GV. BET protein function is required for inflammation: Brd2 genetic disruption and BET inhibitor JQ1 impair mouse macrophage inflammatory responses. J Immunol 2013; 190:3670-8; PMID:23420887; https://doi.org/10.4049/jimmunol.1202838
   PubMed Web of Science ®Google Scholar
• Chen J, Wang Z, Hu X, Chen R, Romero-Gallo J, Peek RM, Jr, Chen LF. BET inhibition attenuates helicobacter pylori-induced inflammatory response by suppressing inflammatory gene transcription and enhancer activation. J Immunol 2016; 196:4132-42; PMID:27084101; https://doi.org/10.4049/jimmunol.1502261
   PubMed Web of Science ®Google Scholar
• Philpott M, Yang J, Tumber T, Fedorov O, Uttarkar S, Filippakopoulos P, Picaud S, Keates T, Felletar I, Ciulli A, et al. Bromodomain-peptide displacement assays for interactome mapping and inhibitor discovery. Mol Biosys 2011; 7:2899-908; PMID:21804994; https://doi.org/10.1039/c1mb05099k
   PubMed Web of Science ®Google Scholar
• Hammitzsch A, Tallant C, Fedorov O, O'Mahony A, Brennan PE, Hay DA, Martinez FO, Al-Mossawi MH, de Wit J, Vecellio M, et al. CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses. Proc Nat Acad Sci U S A 2015; 112:10768-73; PMID:26261308; https://doi.org/10.1073/pnas.1501956112
   PubMed Web of Science ®Google Scholar
• Ghosh S, Taylor A, Chin M, Huang HR, Conery AR, Mertz JA, Salmeron A, Dakle PJ, Mele D, Cote A, et al. Regulatory T cell modulation by CBP/EP300 bromodomain inhibition. J Biol Chem 2016; 291:13014-27; PMID:27056325; https://doi.org/10.1074/jbc.M115.708560
   PubMed Web of Science ®Google Scholar
• Humphreys PG, Bamborough P, Chung CW, Craggs PD, Gordon L, Grandi P, Hayhow TG, Hussain J, Jones KL, Lindon M, et al. Discovery of a potent, cell penetrant and selective p300/CBP-associated factor (PCAF)/General Control Non-Derepressible 5 (GCN5) Bromodomain chemical probe. J Med Chem 2016; 60(2):695-709; PMID:28002667; https://doi.org/10.1021/acs.jmedchem.6b01566
   Web of Science ®Google Scholar
• Moustakim M, Clark PG, Trulli L, Fuentes de Arriba AL, Ehebauer MT, Chaikuad A, Murphy EJ, Mendez-Johnson J, Daniels D, Hou CD, et al. Discovery of a PCAF Bromodomain chemical probe. Angewandte Chemie 2017; 56(3):827-31; PMID:27966810; https://doi.org/10.1002/anie.201610816
   Google Scholar
• Theodoulou NH, Bamborough P, Bannister AJ, Becher I, Bit RA, Che KH, Chung CW, Dittmann A, Drewes G, Drewry DH, et al. Discovery of I-BRD9, a selective cell active chemical probe for bromodomain containing protein 9 inhibition. J Med Chem 2016; 59:1425-39; PMID:25856009; https://doi.org/10.1021/acs.jmedchem.5b00256
   PubMed Web of Science ®Google Scholar
• Zhao R, Liu Y, Wang H, Yang J, Niu W, Fan S, Xiong W, Ma J, Li X, Phillips JB, et al. BRD7 plays an anti-inflammatory role during early acute inflammation by inhibiting activation of the NF-small ka, CyrillicB signaling pathway. Cell Mol Immunol 2016; 13:1-12; PMID:27374794; https://doi.org/10.1038/cmi.2016.31
   Google Scholar
• Shen Y, Szewczyk MM, Eram MS, Smil D, Kaniskan HÜ, Ferreira de Freitas R, Senisterra G, Li F, Schapira M, Brown PJ, et al. Discovery of a potent, selective, and cell-active dual inhibitor of Protein Arginine Methyltransferase 4 and protein arginine Methyltransferase 6. J Med Chem 2016; 59:9124-39; PMID:27584694; https://doi.org/10.1021/acs.jmedchem.6b01033
   PubMed Web of Science ®Google Scholar
• Dimitrova E, Turberfield AH, Klose RJ. Histone demethylases in chromatin biology and beyond. EMBO Rep 2015; 16:1620-39; PMID:26564907; https://doi.org/10.15252/embr.201541113
   PubMed Web of Science ®Google Scholar
• Kruidenier L, Chung CW, Cheng Z, Liddle J, Che K, Joberty G, Bantscheff M, Bountra C, Bridges A, Diallo H, et al. A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response. Nature 2012; 488:404-8; PMID:22842901; https://doi.org/10.1038/nature11262
   PubMed Web of Science ®Google Scholar
• Yang XP, Jiang K, Hirahara K, Vahedi G, Afzali B, Sciume G, Bonelli M, Sun HW, Jankovic D, Kanno Y, et al. EZH2 is crucial for both differentiation of regulatory T cells and T effector cell expansion. Sci Rep 2015; 5:10643; PMID:26090605; https://doi.org/10.1038/srep10643
   PubMed Web of Science ®Google Scholar
• Liu Z, Cao W, Xu L, Chen X, Zhan Y, Yang Q, Liu S, Chen P, Jiang Y, Sun X, et al. The histone H3 lysine-27 demethylase Jmjd3 plays a critical role in specific regulation of Th17 cell differentiation. J Mol Cell Biol 2015; 7:505-16; PMID:25840993; https://doi.org/10.1093/jmcb/mjv022
   PubMed Web of Science ®Google Scholar
• Tennant BR, Hurley P, Dhillon J, Gill A, Whiting C, Hoffman BG. The TrxG complex mediates cytokine induced De Novo enhancer formation in Islets. PloS One 2015; 10:e0141470; PMID:; PMID:26505193; https://doi.org/10.1371/journal.pone.0141470
   PubMed Web of Science ®Google Scholar
• Donas C, Carrasco M, Fritz M, Prado C, Tejón G, Osorio-Barrios F, Manríquez V, Reyes P, Pacheco R, Bono MR, et al. The histone demethylase inhibitor GSK-J4 limits inflammation through the induction of a tolerogenic phenotype on DCs. J Autoimmun 2016; 75:105-17; PMID:27528513; https://doi.org/10.1016/j.jaut.2016.07.011
   PubMed Web of Science ®Google Scholar
• Yapp C, Carr AJ, Price A, Oppermann U, Snelling SJ. H3K27me3 demethylases regulate in vitro chondrogenesis and chondrocyte activity in osteoarthritis. Arthritis Res Ther 2016; 18:158; PMID:27388528; https://doi.org/10.1186/s13075-016-1053-7
   PubMed Web of Science ®Google Scholar
• Na J, Lee K, Na W, Shin JY, Lee MJ, Yune TY, Lee HK, Jung HS, Kim WS, Ju BG. Histone H3K27 demethylase JMJD3 in cooperation with NF-kappaB regulates keratinocyte wound healing. J Invest Dermatol 2016; 136:847-58; PMID:26802933; https://doi.org/10.1016/j.jid.2015.11.029
   PubMed Web of Science ®Google Scholar
• Daigle SR, Olhava EJ, Therkelsen CA, Basavapathruni A, Jin L, Boriack-Sjodin PA, Allain CJ, Klaus CR, Raimondi A, Scott MP, et al. Potent inhibition of DOT1L as treatment of MLL-fusion leukemia. Blood 2013; 122:1017-25; PMID:23801631; https://doi.org/10.1182/blood-2013-04-497644
   PubMed Web of Science ®Google Scholar
• Kruidenier L, Chung CW, Cheng Z, Liddle J, Che K, Joberty G, Bantscheff M, Bountra C, Bridges A, Diallo H, et al. Kruidenier et al. reply. Nature 2014; 514:E2; PMID:25279927; https://doi.org/10.1038/nature13689
   PubMed Web of Science ®Google Scholar
• McAllister TE, England KS, Hopkinson RJ, Brennan PE, Kawamura A, Schofield CJ. Recent progress in Histone Demethylase Inhibitors. J Med Chem 2016; 59:1308-29; PMID:26710088; https://doi.org/10.1021/acs.jmedchem.5b01758
   PubMed Web of Science ®Google Scholar
• Gantier MP, Stunden HJ, McCoy CE, Behlke MA, Wang D, Kaparakis-Liaskos M, Sarvestani ST, Yang YH, Xu D, Corr SC, et al. A miR-19 regulon that controls NF-kappaB signaling. Nucl Acids Res 2012; 40:8048-58; PMID:22684508; https://doi.org/10.1093/nar/gks521
   PubMed Web of Science ®Google Scholar
• Erdogan O, Xie L, Wang L, Wu B, Kong Q, Wan Y, Chen X. Proteomic dissection of LPS-inducible, PHF8-dependent secretome reveals novel roles of PHF8 in TLR4-induced acute inflammation and T cell proliferation. Sci Rep 2016; 6:24833; PMID:27112199; https://doi.org/10.1038/srep24833
   PubMed Web of Science ®Google Scholar
• Lewis HD, Liddle J, Coote JE, Atkinson SJ, Barker MD, Bax BD, Bicker KL, Bingham RP, Campbell M, Chen YH, et al. Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation. Nat Chem Biol 2015; 11:189; PMID:25622091; https://doi.org/10.1038/nchembio.1735
   PubMed Web of Science ®Google Scholar
• Alam H, Gu B, Lee MG. Histone methylation modifiers in cellular signaling pathways. Cell Mol Life Sci 2015; 72:4577-92; PMID:26305020; https://doi.org/10.1007/s00018-015-2023-y
   PubMed Web of Science ®Google Scholar
• Lu T, Stark GR. Using sequential immunoprecipitation and mass spectrometry to identify methylation of NF-kappaB. Methods Mol Biol 2015; 1280:383-93; PMID:25736762; https://doi.org/10.1007/978-1-4939-2422-6_23
   PubMedGoogle Scholar
• Kim JH, Yoo BC, Yang WS, Kim E, Hong S, Cho JY. The role of protein arginine methyltransferases in inflammatory responses. Mediators Inflamm 2016; 2016:4028353; PMID:27041824; https://doi.org/10.1155/2016/4028353
   PubMedGoogle Scholar
• Li Y, Reddy MA, Miao F, Shanmugam N, Yee JK, Hawkins D, Ren B, Natarajan R. Role of the histone H3 lysine 4 methyltransferase, SET7/9, in the regulation of NF-kappaB-dependent inflammatory genes. Relevance to diabetes and inflammation. J Biol Chem 2008; 283:26771-81; PMID:18650421; https://doi.org/10.1074/jbc.M802800200
   PubMed Web of Science ®Google Scholar
• Chen X, El Gazzar M, Yoza BK, McCall CE. The NF-kappaB factor RelB and histone H3 lysine methyltransferase G9a directly interact to generate epigenetic silencing in endotoxin tolerance. J Biol Chem 2009; 284:27857-65; PMID:19690169; https://doi.org/10.1074/jbc.M109.000950
   PubMed Web of Science ®Google Scholar
• Lu T, Jackson MW, Wang B, Yang M, Chance MR, Miyagi M, Gudkov AV, Stark GR. Regulation of NF-kappaB by NSD1/FBXL11-dependent reversible lysine methylation of p65. Proc Natl Acad Sci U S A 2010; 107:46-51; PMID:20080798; https://doi.org/10.1073/pnas.0912493107
   PubMed Web of Science ®Google Scholar
• Levy D, Kuo AJ, Chang Y, Schaefer U, Kitson C, Cheung P, Espejo A, Zee BM, Liu CL, Tangsombatvisit S, et al. Lysine methylation of the NF-kappaB subunit RelA by SETD6 couples activity of the histone methyltransferase GLP at chromatin to tonic repression of NF-kappaB signaling. Nat Immunol 2011; 12:29-36; PMID:21131967; https://doi.org/10.1038/ni.1968
   PubMed Web of Science ®Google Scholar
• Stender JD, Pascual G, Liu W, Kaikkonen MU, Do K, Spann NJ, Boutros M, Perrimon N, Rosenfeld MG, Glass CK. Control of proinflammatory gene programs by regulated trimethylation and demethylation of histone H4K20. Mol Cell 2012; 48:28-38; PMID:22921934; https://doi.org/10.1016/j.molcel.2012.07.020
   PubMed Web of Science ®Google Scholar
• Wei H, Wang B, Miyagi M, She Y, Gopalan B, Huang DB, Ghosh G, Stark GR, Lu T. PRMT5 dimethylates R30 of the p65 subunit to activate NF-kappaB. Proc Natl Acad Sci U S A 2013; 110:13516-21; PMID:23904475; https://doi.org/10.1073/pnas.1311784110
   PubMed Web of Science ®Google Scholar
• Harris DP, Chandrasekharan UM, Bandyopadhyay S, Willard B, DiCorleto PE. PRMT5-Mediated Methylation of NF-kappaB p65 at Arg174 Is Required for Endothelial CXCL11 Gene Induction in Response to TNF-alpha and IFN-gamma Costimulation. PloS One 2016; 11:e0148905; PMID:26901772; https://doi.org/10.1371/journal.pone.0148905
   PubMed Web of Science ®Google Scholar
• Fan Z, Kong X, Xia J, Wu X, Li H, Xu H, Fang M, Xu Y. The arginine methyltransferase PRMT5 regulates CIITA-dependent MHC II transcription. Biochim Et Biophys Acta 2016; 1859:687-96; PMID:26972221; https://doi.org/10.1016/j.bbagrm.2016.03.004
   PubMedGoogle Scholar
• Sun Q, Yang X, Zhong B, Jiao F, Li C, Li D, Lan X, Sun J, Lu S. Upregulated protein arginine methyltransferase 1 by IL-4 increases eotaxin-1 expression in airway epithelial cells and participates in antigen-induced pulmonary inflammation in rats. J Immunol 2012; 188:3506-12; PMID:22387551; https://doi.org/10.4049/jimmunol.1102635
   PubMed Web of Science ®Google Scholar
• Park MJ, Kim DI, Lim SK, Choi JH, Kim JC, Yoon KC, Lee JB, Lee JH, Han HJ, Choi IP, et al. Thioredoxin-interacting protein mediates hepatic lipogenesis and inflammation via PRMT1 and PGC-1alpha regulation in vitro and in vivo. J Hepatol 2014; 61:1151-7; PMID:25003952; https://doi.org/10.1016/j.jhep.2014.06.032
   PubMed Web of Science ®Google Scholar
• Sun Q, Liu L, Roth M, Tian J, He Q, Zhong B, Bao R, Lan X, Jiang C, Sun J, et al. PRMT1 upregulated by epithelial proinflammatory cytokines participates in COX2 expression in fibroblasts and chronic antigen-induced pulmonary inflammation. J Immunol 2015; 195:298-306; PMID:26026059; https://doi.org/10.4049/jimmunol.1402465
   PubMed Web of Science ®Google Scholar
• Liu L, Sun Q, Bao R, Roth M, Zhong B, Lan X, Tian J, He Q, Li D, Sun J, et al. Specific regulation of PRMT1 expression by PIAS1 and RKIP in BEAS-2B epithelia cells and HFL-1 fibroblasts in lung inflammation. Sc Rep 2016; 6:21810; PMID:26911452; https://doi.org/10.1038/srep21810
   PubMedGoogle Scholar
• Reintjes A, Fuchs JE, Kremser L, Lindner HH, Liedl KR, Huber LA, Valovka T. Asymmetric arginine dimethylation of RelA provides a repressive mark to modulate TNFalpha/NF-kappaB response. Proc Natl Acad Sci U S A 2016; 113:4326-31; PMID:27051065; https://doi.org/10.1073/pnas.1522372113
   PubMed Web of Science ®Google Scholar
• Sun Q, Liu L, Mandal J, Molino A, Stolz D, Tamm M, Lu S, Roth M. PDGF-BB induces PRMT1 expression through ERK1/2 dependent STAT1 activation and regulates remodeling in primary human lung fibroblasts. Cell Signal 2016; 28:307-15; PMID:26795953; https://doi.org/10.1016/j.cellsig.2016.01.004
   PubMed Web of Science ®Google Scholar
• Di Lorenzo A, Yang Y, Macaluso M, Bedford MT. A gain-of-function mouse model identifies PRMT6 as a NF-kappaB coactivator. Nucleic Acid Res 2014; 42:8297-309; PMID:24939901; https://doi.org/10.1093/nar/gku530
   PubMed Web of Science ®Google Scholar
• Xu G, Liu G, Xiong S, Liu H, Chen X, Zheng B. The histone methyltransferase Smyd2 is a negative regulator of macrophage activation by suppressing interleukin 6 (IL-6) and tumor necrosis factor alpha (TNF-alpha) production. J Biol Chem 2015; 290:5414-23; PMID:25583990; https://doi.org/10.1074/jbc.M114.610345
   PubMed Web of Science ®Google Scholar
• Barroso M, Kao D, Blom HJ, Tavares de Almeida I, Castro R, Loscalzo J, Handy DE. S-adenosylhomocysteine induces inflammation through NFkB: A possible role for EZH2 in endothelial cell activation. Biochim Et Biophy Acta 2016; 1862:82-92; PMID:26506125; https://doi.org/10.1016/j.bbadis.2015.10.019
   PubMed Web of Science ®Google Scholar
• Hachiya R, Shiihashi T, Shirakawa I, Iwasaki Y, Matsumura Y, Oishi Y, Nakayama Y, Miyamoto Y, Manabe I, Ochi K, et al. The H3K9 methyltransferase Setdb1 regulates TLR4-mediated inflammatory responses in macrophages. Sci Rep 2016; 6:28845; PMID:27349785; https://doi.org/10.1038/srep28845
   PubMed Web of Science ®Google Scholar
• Comstedt P, Storgaard M, Lassen AT. The Systemic Inflammatory Response Syndrome (SIRS) in acutely hospitalised medical patients: a cohort study. Scand J Trauma Resus Emerg Med 2009; 17:67; PMID:20035633; https://doi.org/10.1186/1757-7241-17-67
   PubMed Web of Science ®Google Scholar
• Eram MS, Shen Y, Szewczyk MM, Wu H, Senisterra G, Li F, Butler KV, Kaniskan HÜ, Speed BA, dela Seña C, et al. A potent, selective, and cell-active inhibitor of human Type I protein arginine methyltransferases. ACS Chem Biol 2016; 11:772-81; PMID:26598975; https://doi.org/10.1021/acschembio.5b00839
   PubMed Web of Science ®Google Scholar
• Steffan JS, Bodai L, Pallos J, Poelman M, McCampbell A, Apostol BL, Kazantsev A, Schmidt E, Zhu YZ, Greenwald M, et al. Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature 2001; 413:739-43; PMID:11607033; https://doi.org/10.1038/35099568
   PubMed Web of Science ®Google Scholar
• Klein CJ, Botuyan MV, Wu Y, Ward CJ, Nicholson GA, Hammans S, Hojo K, Yamanishi H, Karpf AR, Wallace DC, et al. Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss. Nat Gen 2011; 43:595-600; PMID:21532572; https://doi.org/10.1038/ng.830
   PubMed Web of Science ®Google Scholar
• Winkelmann J, Lin L, Schormair B, Kornum BR, Faraco J, Plazzi G, Melberg A, Cornelio F, Urban AE, Pizza F, et al. Mutations in DNMT1 cause autosomal dominant cerebellar ataxia, deafness and narcolepsy. Hum Mol Gen 2012; 21:2205-10; PMID:22328086; https://doi.org/10.1093/hmg/dds035
   PubMed Web of Science ®Google Scholar
• Heppner FL, Ransohoff RM, Becher B. Immune attack: the role of inflammation in Alzheimer disease. Nat Rev Neurosci 2015; 16:358-72; PMID:25991443; https://doi.org/10.1038/nrn3880
   PubMed Web of Science ®Google Scholar
• Dong X, Tsuji J, Labadorf A, Roussos P, Chen JF, Myers RH, Akbarian S, Weng Z. The role of H3K4me3 in transcriptional regulation is altered in Huntington's disease. PloS One 2015; 10:e0144398; PMID:26636336; https://doi.org/10.1371/journal.pone.0144398
   PubMed Web of Science ®Google Scholar
• Verma SK, Tian X, LaFrance LV, Duquenne C, Suarez DP, Newlander KA, Romeril SP, Burgess JL, Grant SW, Brackley JA, et al. Identification of potent, selective, cell-active inhibitors of the histone lysine Methyltransferase EZH2. ACS Med Chem Lett 2012; 3:1091-6; PMID:24900432; https://doi.org/10.1021/ml3003346
   PubMed Web of Science ®Google Scholar
• Tripathy MK, McManamy ME, Burch BD, Archin NM, Margolis DM. H3K27 demethylation at the proviral promoter sensitizes latent HIV to the effects of vorinostat in Ex vivo cultures of resting CD4+ T Cells. J Virol 2015; 89:8392-405; PMID:26041287; https://doi.org/10.1128/JVI.00572-15
   PubMed Web of Science ®Google Scholar
• Knutson SK, Wigle TJ, Warholic NM, Sneeringer CJ, Allain CJ, Klaus CR, Sacks JD, Raimondi A, Majer CR, Song J, et al. A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells. Nat Chem Biol 2012; 8:890-6; PMID:23023262; https://doi.org/10.1038/nchembio.1084
   PubMed Web of Science ®Google Scholar
• Scaramuzzino C, Casci I, Parodi S, Lievens PM, Polanco MJ, Milioto C, Chivet M, Monaghan J, Mishra A, Badders N, et al. Protein arginine methyltransferase 6 enhances polyglutamine-expanded androgen receptor function and toxicity in spinal and bulbar muscular atrophy. Neuron 2015; 85:88-100; PMID:25569348; https://doi.org/10.1016/j.neuron.2014.12.031
   PubMed Web of Science ®Google Scholar
• Hossein-Nezhad A, Fatemi RP, Ahmad R, Peskind ER, Zabetian CP, Hu SC, Shi M, Wahlestedt C, Zhang J, Faghihi MA. Transcriptomic profiling of extracellular RNAs present in cerebrospinal fluid identifies differentially expressed transcripts in Parkinson's disease. J Parkinson's Dis 2016; 6:109-17; PMID:26889637; https://doi.org/10.3233/JPD-150737
   PubMedGoogle Scholar
• Grootjans J, Kaser A, Kaufman RJ, Blumberg RS. The unfolded protein response in immunity and inflammation. Nat Rev Immunol 2016; 16:469-84; PMID:27346803; https://doi.org/10.1038/nri.2016.62
   PubMed Web of Science ®Google Scholar
• Moreno JA, Halliday M, Molloy C, Radford H, Verity N, Axten JM, Ortori CA, Willis AE, Fischer PM, Barrett DA, et al. Oral treatment targeting the unfolded protein response prevents neurodegeneration and clinical disease in prion-infected mice. Sci Transl Med 2013; 5:206ra138; PMID:24107777; https://doi.org/10.1126/scitranslmed.300676
   PubMed Web of Science ®Google Scholar
• Todd DJ, Lee AH, Glimcher LH. The endoplasmic reticulum stress response in immunity and autoimmunity. Nat Rev Immunol 2008; 8:663-74; PMID:18670423; https://doi.org/10.1038/nri2359
   PubMed Web of Science ®Google Scholar
• Zhang K, Kaufman RJ. From endoplasmic-reticulum stress to the inflammatory response. Nature 2008; 454:455-62; PMID:18650916; https://doi.org/10.1038/nature07203
   PubMed Web of Science ®Google Scholar
• Yu W, Chory EJ, Wernimont AK, Tempel W, Scopton A, Federation A, Marineau JJ, Qi J, Barsyte-Lovejoy D, Yi J, et al. Catalytic site remodelling of the DOT1L methyltransferase by selective inhibitors. Nat Communicat 2012; 3:1288; PMID:23250418; https://doi.org/10.1038/ncomms2304
   PubMed Web of Science ®Google Scholar
• Roidl D, Hellbach N, Bovio PP, Villarreal A, Heidrich S, Nestel S, Grüning BA, Boenisch U, Vogel T. DOT1L Activity promotes proliferation and protects cortical neural stem cells from activation of ATF4-DDIT3-Mediated ER stress In vitro. Stem Cells 2016; 34:233-45; PMID:26299268; https://doi.org/10.1002/stem.2187
   PubMed Web of Science ®Google Scholar
• Suarez-Calvet M, Neumann M, Arzberger T, Abou-Ajram C, Funk E, Hartmann H, Edbauer D, Kremmer E, Göbl C, Resch M, et al. Monomethylated and unmethylated FUS exhibit increased binding to Transportin and distinguish FTLD-FUS from ALS-FUS. Acta Neuropathologica 2016; 131:587-604; PMID:26895297; https://doi.org/10.1007/s00401-016-1544-2
   PubMed Web of Science ®Google Scholar
• Tibshirani M, Tradewell ML, Mattina KR, Minotti S, Yang W, Zhou H, Strong MJ, Hayward LJ, Durham HD. Cytoplasmic sequestration of FUS/TLS associated with ALS alters histone marks through loss of nuclear protein arginine methyltransferase 1. Hum Mol Gen 2015; 24:773-86; PMID:25274782; https://doi.org/10.1093/hmg/ddu494
   PubMed Web of Science ®Google Scholar
• Kim HJ, Jeong MH, Kim KR, Jung CY, Lee SY, Kim H, Koh J, Vuong TA, Jung S, Yang H, et al. Protein arginine methylation facilitates KCNQ channel-PIP2 interaction leading to seizure suppression. eLife 2016; 5:e17159; PMID:27466704; https://doi.org/10.7554/eLife.17159
   Web of Science ®Google Scholar
• Wright KL, Ting JP. Epigenetic regulation of MHC-II and CIITA genes. Trend Immunol 2006; 27:405-12; PMID:16870508; https://doi.org/10.1016/j.it.2006.07.007
   PubMed Web of Science ®Google Scholar
• Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007; 448:427-34; PMID:17653185; https://doi.org/10.1038/nature06005
   PubMed Web of Science ®Google Scholar
• Antignano F, Burrows K, Hughes MR, Han JM, Kron KJ, Penrod NM, Oudhoff MJ, Wang SK, Min PH, Gold MJ, et al. Methyltransferase G9A regulates T cell differentiation during murine intestinal inflammation. J Clin Invest 2014; 124:1945-55; PMID:24667637; https://doi.org/10.1172/JCI69592
   PubMed Web of Science ®Google Scholar
• Nakanishi Y, Reina-Campos M, Nakanishi N, Llado V, Elmen L, Peterson S, Campos A, De SK, Leitges M, Ikeuchi H, et al. Control of Paneth cell fate, intestinal inflammation, and tumorigenesis by PKClambda/iota. Cell Reports 2016; 16:3297-310; PMID:27653691; https://doi.org/10.1016/j.celrep.2016.08.054
   PubMed Web of Science ®Google Scholar
• Lehnertz B, Northrop JP, Antignano F, Burrows K, Hadidi S, Mullaly SC, Rossi FM, Zaph C. Activating and inhibitory functions for the histone lysine methyltransferase G9a in T helper cell differentiation and function. J Exp Med 2010; 207:915-22; PMID:20421388; https://doi.org/10.1084/jem.20100363
   PubMed Web of Science ®Google Scholar
• Kind J, Pagie L, Ortabozkoyun H, Boyle S, de Vries SS, Janssen H, Amendola M, Nolen LD, Bickmore WA, van Steensel B. Single-cell dynamics of genome-nuclear lamina interactions. Cell 2013; 153:178-92; PMID:23523135; https://doi.org/10.1016/j.cell.2013.02.028
   PubMed Web of Science ®Google Scholar
• Montes de Oca R, Andreassen PR, Wilson KL. Barrier-to-Autointegration Factor influences specific histone modifications. Nucleus 2011; 2:580-90; PMID:22127260; https://doi.org/10.4161/nucl.2.6.17960
   PubMed Web of Science ®Google Scholar
• Vedadi M, Barsyte-Lovejoy D, Liu F, Rival-Gervier S, Allali-Hassani A, Labrie V, Wigle TJ, Dimaggio PA, Wasney GA, Siarheyeva A, et al. A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cells. Nat Chem Biol 2011; 7:566-74; PMID:21743462; https://doi.org/10.1038/nchembio.599
   PubMed Web of Science ®Google Scholar
• Kubicek S, O'Sullivan RJ, August EM, Hickey ER, Zhang Q, Teodoro ML, Rea S, Mechtler K, Kowalski JA, Homon CA, et al. Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase. Mol Cell 2007; 25:473-81; PMID:17289593; https://doi.org/10.1016/j.molcel.2007.01.017
   PubMed Web of Science ®Google Scholar
• Cadwell K, Liu JY, Brown SL, Miyoshi H, Loh J, Lennerz JK, Kishi C, Kc W, Carrero JA, Hunt S, et al. A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nat 2008; 456:259-63; PMID:18849966; https://doi.org/10.1038/nature07416
   PubMed Web of Science ®Google Scholar
• Wu SC, Zhang Y. Cyclin-dependent kinase 1 (CDK1)-mediated phosphorylation of enhancer of zeste 2 (Ezh2) regulates its stability. J Biol Chem 2011; 286:28511-9; PMID:21659531; https://doi.org/10.1074/jbc.M111.240515
   PubMed Web of Science ®Google Scholar
• Koppens MA, Bounova G, Gargiulo G, Tanger E, Janssen H, Cornelissen-Steijger P, Blom M, Song JY, Wessels LF, van Lohuizen M. Deletion of polycomb repressive Complex 2 from mouse intestine causes loss of stem cells. Gastroenterol 2016; 151:684-97 e612; PMID:27342214; https://doi.org/10.1053/j.gastro.2016.06.020
   PubMed Web of Science ®Google Scholar
• Taube R, Peterlin M. Lost in transcription: molecular mechanisms that control HIV latency. Viruses 2013; 5:902-27; PMID:23518577; https://doi.org/10.3390/v5030902
   PubMed Web of Science ®Google Scholar
• Polizzotto MN, Chen G, Tressler RL, Godfrey C. Leveraging Cancer Therapeutics for the HIV Cure Agenda: current status and future directions. Drugs 2015; 75:1447-59; PMID:26224205; https://doi.org/10.1007/s40265-015-0426-6
   PubMed Web of Science ®Google Scholar
• Banerjee C, Archin N, Michaels D, Belkina AC, Denis GV, Bradner J, Sebastiani P, Margolis DM, Montano M. BET bromodomain inhibition as a novel strategy for reactivation of HIV-1. J Leukocyte Biol 2012; 92:1147-54; PMID:22802445; https://doi.org/10.1189/jlb.0312165
   PubMed Web of Science ®Google Scholar
• Jiang G, Mendes EA, Kaiser P, Sankaran-Walters S, Tang Y, Weber MG, Melcher GP, Thompson GR 3rd, Tanuri A, Pianowski LF, et al. Reactivation of HIV latency by a newly modified Ingenol derivative via protein kinase Cdelta-NF-kappaB signaling. Aids 2014; 28:1555-66; PMID:24804860; https://doi.org/10.1097/QAD.0000000000000289
   PubMed Web of Science ®Google Scholar
• Jiang G, Mendes EA, Kaiser P, Wong DP, Tang Y, Cai I, Fenton A, Melcher GP, Hildreth JE, Thompson GR, et al. Synergistic reactivation of latent HIV expression by Ingenol-3-Angelate, PEP005, Targeted NF-kB signaling in combination with JQ1 Induced p-TEFb activation. PLoS Pathogens 2015; 11:e1005066; PMID:26225771; https://doi.org/10.1371/journal.ppat.1005066
   PubMed Web of Science ®Google Scholar
• Darcis G, Kula A, Bouchat S, Fujinaga K, Corazza F, Ait-Ammar A, Delacourt N, Melard A, Kabeya K, Vanhulle C, et al. An In-Depth comparison of latency-reversing agent combinations in various in Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B+JQ1 to potently reactivate viral gene expression. PLoS Pathogens 2015; 11:e1005063; PMID:26225566; https://doi.org/10.1371/journal.ppat.1005063
   PubMed Web of Science ®Google Scholar
• Lu P, Qu X, Shen Y, Jiang Z, Wang P, Zeng H, Ji H, Deng J, Yang X, Li X, et al. The BET inhibitor OTX015 reactivates latent HIV-1 through P-TEFb. Sci Rep 2016; 6:24100; PMID:27067814; https://doi.org/10.1038/srep24100
   PubMed Web of Science ®Google Scholar
• Boehm D, Calvanese V, Dar RD, Xing S, Schroeder S, Martins L, Aull K, Li PC, Planelles V, Bradner JE, et al. BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism. Cell Cycle 2013; 12:452-62; PMID:23255218; https://doi.org/10.4161/cc.23309
   PubMed Web of Science ®Google Scholar
• Zhang HS, Du GY, Liu Y, Zhang ZG, Zhou Z, Li H, Dai KQ, Yu XY, Gou XM. UTX-1 regulates Tat-induced HIV-1 transactivation via changing the methylated status of histone H3. Inter J Biochem Cell Biol 2016; 80:51-56; PMID:27671333; https://doi.org/10.1016/j.biocel.2016.09.016
   PubMed Web of Science ®Google Scholar
• Messer HG, Jacobs D, Dhummakupt A, Bloom DC. Inhibition of H3K27me3-specific histone demethylases JMJD3 and UTX blocks reactivation of herpes simplex virus 1 in trigeminal ganglion neurons. J Virol 2015; 89:3417-20; PMID:25552720; https://doi.org/10.1128/JVI.03052-14
   PubMed Web of Science ®Google Scholar
• Imai K, Togami H, Okamoto T. Involvement of histone H3 lysine 9 (H3K9) methyltransferase G9a in the maintenance of HIV-1 latency and its reactivation by BIX01294. J Biol Chem 2010; 285:16538-45; PMID:20335163; https://doi.org/10.1074/jbc.M110.103531
   PubMed Web of Science ®Google Scholar
• Friedman J, Cho WK, Chu CK, Keedy KS, Archin NM, Margolis DM, Karn J. Epigenetic silencing of HIV-1 by the histone H3 lysine 27 methyltransferase enhancer of Zeste 2. J Virol 2011; 85:9078-89; PMID:21715480; https://doi.org/10.1128/JVI.00836-11
   PubMed Web of Science ®Google Scholar
• Matsuda Y, Kobayashi-Ishihara M, Fujikawa D, Ishida T, Watanabe T, Yamagishi M. Epigenetic heterogeneity in HIV-1 latency establishment. Sci Rep 2015; 5:7701; PMID:25572573; https://doi.org/10.1038/srep07701
   PubMed Web of Science ®Google Scholar
• Fulcher AJ, Jans DA. The HIV-1 Tat transactivator protein: a therapeutic target? IUBMB Life 2003; 55:669-80; PMID:14769003; https://doi.org/10.1080/15216540310001643440
   PubMed Web of Science ®Google Scholar
• Mizutani T, Ishizaka A, Tomizawa M, Okazaki T, Yamamichi N, Kawana-Tachikawa A, Iwamoto A, Iba H. Loss of the Brm-type SWI/SNF chromatin remodeling complex is a strong barrier to the Tat-independent transcriptional elongation of human immunodeficiency virus type 1 transcripts. J Virol 2009; 83:11569-80; PMID:19726504; https://doi.org/10.1128/JVI.00742-09
   PubMed Web of Science ®Google Scholar
• Sivakumaran H, van der Horst A, Fulcher AJ, Apolloni A, Lin MH, Jans DA, Harrich D. Arginine methylation increases the stability of human immunodeficiency virus type 1 Tat. J Virol 2009; 83:11694-703; PMID:19726520; https://doi.org/10.1128/JVI.00499-09
   PubMed Web of Science ®Google Scholar
• Xie B, Invernizzi CF, Richard S, Wainberg MA. Arginine methylation of the human immunodeficiency virus type 1 Tat protein by PRMT6 negatively affects Tat Interactions with both cyclin T1 and the Tat transactivation region. J Virol 2007; 81:4226-34; PMID:17267505; https://doi.org/10.1128/JVI.01888-06
   PubMed Web of Science ®Google Scholar
• Sivakumaran H, Lin MH, Apolloni A, Cutillas V, Jin H, Li D, Wei T, Harrich D. Overexpression of PRMT6 does not suppress HIV-1 Tat transactivation in cells naturally lacking PRMT6. Virol J 2013; 10:207; PMID:23800116; https://doi.org/10.1186/1743-422X-10-207
   PubMed Web of Science ®Google Scholar
• Church ME, Estrada M, Leutenegger CM, Dela Cruz FN, Pesavento PA, Woolard KD. BRD4 is associated with Raccoon Polyomavirus (RacPyV) genome and mediates viral gene transcription and maintenance of a stem cell state in neuroglial tumor cells. J Gen Virol 2016; 97:2939-48; PMID:27600312; https://doi.org/10.1099/jgv.0.000594
   PubMed Web of Science ®Google Scholar
• Wollebo HS, Bellizzi A, Cossari DH, Salkind J, Safak M, White MK. The Brd4 acetyllysine-binding protein is involved in activation of polyomavirus JC. J Neurovirol 2016; 22(5):615-25; PMID:27007123; https://doi.org/10.1007/s13365-016-0435-6
   PubMed Web of Science ®Google Scholar
• Zhou H, Schmidt SC, Jiang S, Willox B, Bernhardt K, Liang J, Johannsen EC, Kharchenko P, Gewurz BE, Kieff E, et al. Epstein-Barr virus oncoprotein super-enhancers control B cell growth. Cell Host Microb 2015; 17:205-16; PMID:25639793; https://doi.org/10.1016/j.chom.2014.12.013
   PubMed Web of Science ®Google Scholar
• Palermo RD, Webb HM, West MJ. RNA polymerase II stalling promotes nucleosome occlusion and pTEFb recruitment to drive immortalization by Epstein-Barr virus. PLoS Pathogens 2011; 7:e1002334; PMID:22046134; https://doi.org/10.1371/journal.ppat.1002334
   PubMed Web of Science ®Google Scholar
• Chang SW, Liu WC, Liao KY, Tsao YP, Hsu PH, Chen SL. Phosphorylation of HPV-16 E2 at serine 243 enables binding to Brd4 and mitotic chromosomes. PloS One 2014; 9:e110882; PMID:25340539; https://doi.org/10.1371/journal.pone.0110882
   PubMed Web of Science ®Google Scholar
• Helfer CM, Yan J, You J. The cellular bromodomain protein Brd4 has multiple functions in E2-mediated papillomavirus transcription activation. Viruses 2014; 6:3228-49; PMID:25140737; https://doi.org/10.3390/v6083228
   PubMed Web of Science ®Google Scholar
• Wang X, Helfer CM, Pancholi N, Bradner JEM, You J. Recruitment of Brd4 to the human papillomavirus type 16 DNA replication complex is essential for replication of viral DNA. J Virol 2013; 87:3871-84; PMID:23365439; https://doi.org/10.1128/JVI.03068-12
   PubMed Web of Science ®Google Scholar
• Jung GS, Jeon JH, Choi YK, Jang SY, Park SY, Kim SW, Byun JK, Kim MK, Lee S, Shin EC, et al. Pyruvate dehydrogenase kinase regulates hepatitis C virus replication. Sci Rep 2016; 6:30846; PMID:27471054; https://doi.org/10.1038/srep30846
   PubMed Web of Science ®Google Scholar
• Wang X, Li J, Schowalter RM, Jiao J, Buck CB, You J. Bromodomain protein Brd4 plays a key role in Merkel cell polyomavirus DNA replication. PLoS Pathogens 2012; 8:e1003021; PMID:23144621; https://doi.org/10.1371/journal.ppat.1003021
   PubMed Web of Science ®Google Scholar
• Sharma A, Larue RC, Plumb MR, Malani N, Male F, Slaughter A, Kessl JJ, Shkriabai N, Coward E, Aiyer SS, et al. BET proteins promote efficient murine leukemia virus integration at transcription start sites. Proc Nat Acad Sci U S A 2013; 110:12036-41; PMID: 23818621; https://doi.org/10.1073/pnas.1307157110
   PubMed Web of Science ®Google Scholar
• Gupta SS, Maetzig T, Maertens GN, Sharif A, Rothe M, Weidner-Glunde M, Galla M, Schambach A, Cherepanov P, Schulz TF. Bromo- and extraterminal domain chromatin regulators serve as cofactors for murine leukemia virus integration. J Virol 2013; 87:12721-36; PMID:24049186; https://doi.org/10.1128/JVI.01942-13
   PubMed Web of Science ®Google Scholar
• Thomas M, Sonntag E, Müller R, Schmidt S, Zielke B, Fossen T, Stamminger T. pUL69 of human cytomegalovirus recruits the cellular protein Arginine Methyltransferase 6 via a domain that is crucial for mRNA export and efficient viral replication. J Virol 2015; 89:9601-15; PMID:26178996; https://doi.org/10.1128/JVI.01399-15
   PubMed Web of Science ®Google Scholar
• Friedrich S, Schmidt T, Schierhorn A, Lilie H, Szczepankiewicz G, Bergs S, Liebert UG, Golbik RP, Behrens SE. Arginine methylation enhances the RNA chaperone activity of the West Nile virus host factor AUF1 p45. Rna 2016; 22:1574-91; PMID:27520967; https://doi.org/10.1261/rna.055269.115
   PubMed Web of Science ®Google Scholar
• Han T, Wan Y, Wang J, Zhao P, Yuan Y, Wang L, She Y, Broering R, Lu M, Ye L, et al. Set7 facilitates hepatitis C virus replication via enzymatic activity-dependent attenuation of the IFN-related pathway. J Immunol 2015; 194:2757-68; PMID:25681344; https://doi.org/10.4049/jimmunol.1400583
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhong H, Xie X, Chen CY, Huang D, Shen L, Zhang H, Chen ZW, Zeng G. Long noncoding RNA derived from CD244 signaling epigenetically controls CD8+ T-cell immune responses in tuberculosis infection. Proc Natl Acad Sci U S A 2015; 112:E3883-92; PMID:26150504; https://doi.org/10.1073/pnas.1501662112
   PubMed Web of Science ®Google Scholar
• Ciccarelli M, Vastolo V, Albano L, Lecce M, Cabaro S, Liotti A, Longo M, Oriente F, Russo GL, Macchia PE, et al. Glucose-induced expression of the homeotic transcription factor Prep1 is associated with histone post-translational modifications in skeletal muscle. Diabetologia 2016; 59:176-86; PMID:26453063; https://doi.org/10.1007/s00125-015-3774-6
   PubMed Web of Science ®Google Scholar
• Goru SK, Kadakol A, Pandey A, Malek V, Sharma N, Gaikwad AB. Histone H2AK119 and H2BK120 mono-ubiquitination modulate SET7/9 and SUV39H1 in type 1 diabetes-induced renal fibrosis. Biochem J 2016; 473:3937-49; PMID:27582499; https://doi.org/10.1042/BCJ20160595
   PubMed Web of Science ®Google Scholar
• Yuan H, Reddy MA, Deshpande S, Jia Y, Park JT, Lanting LL, Jin W, Kato M, Xu ZG, Das S. Epigenetic histone modifications involved in profibrotic gene regulation by 12/15-Lipoxygenase and its oxidized lipid products in diabetic nephropathy. Antioxid Redox Signal 2016; 24:361-75; PMID:26492974; https://doi.org/10.1089/ars.2015.6372
   PubMed Web of Science ®Google Scholar
• Paneni F, Costantino S, Battista R, Castello L, Capretti G, Chiandotto S, Scavone G, Villano A, Pitocco D, Lanza G, et al. Adverse epigenetic signatures by histone methyltransferase Set7 contribute to vascular dysfunction in patients with type 2 diabetes mellitus. Circ Cardiovasc Gen 2015; 8:150-8; PMID:25472959; https://doi.org/10.1161/CIRCGENETICS.114.000671
   PubMed Web of Science ®Google Scholar
• Maganti AV, Maier B, Tersey SA, Sampley ML, Mosley AL, Özcan S, Pachaiyappan B, Woster PM, Hunter CS, Stein R, et al. Transcriptional activity of the islet beta cell factor Pdx1 is augmented by lysine methylation catalyzed by the methyltransferase Set7/9. J Biol Chem 2015; 290:9812-22; PMID:25713082; https://doi.org/10.1074/jbc.M114.616219
   PubMed Web of Science ®Google Scholar
• Son MJ, Kim WK, Oh KJ, Park A, Lee da S, Han BS, Lee SC, Bae KH. Methyltransferase and demethylase profiling studies during brown adipocyte differentiation. BMB Rep 2016; 49:388-93; PMID:27157542; https://doi.org/10.5483/BMBRep.2016.49.7.062
   PubMed Web of Science ®Google Scholar
• LeBlanc SE, Wu Q, Lamba P, Sif S, Imbalzano AN. Promoter-enhancer looping at the PPARgamma2 locus during adipogenic differentiation requires the Prmt5 methyltransferase. Nucl Acid Res 2016; 44:5133-47; PMID:26935580; https://doi.org/10.1093/nar/gkw129
   PubMed Web of Science ®Google Scholar
• Yi SA, Um SH, Lee J, Yoo JH, Bang SY, Park EK, Lee MG, Nam KH, Jeon YJ, Park JW, et al. S6K1 phosphorylation of H2B mediates EZH2 trimethylation of H3: A determinant of early adipogenesis. Mol Cell 2016; 62:443-52; PMID:27151441; https://doi.org/10.1016/j.molcel.2016.03.011
   PubMed Web of Science ®Google Scholar
• Claycombe KJ, Vomhof-DeKrey EE, Garcia R, Johnson WT, Uthus E, Roemmich JN. Decreased beige adipocyte number and mitochondrial respiration coincide with increased histone methyl transferase (G9a) and reduced FGF21 gene expression in Sprague-Dawley rats fed prenatal low protein and postnatal high-fat diets. J Nutrit Biochem 2016; 31:113-21; PMID:27133430; https://doi.org/10.1016/j.jnutbio.2016.01.008
   PubMed Web of Science ®Google Scholar
• Kim DI, Park MJ, Choi JH, Kim IS, Han HJ, Yoon KC, Park SW, Lee MY, Oh KS, Park SH. PRMT1 and PRMT4 regulate oxidative stress-induced retinal pigment epithelial cell damage in SIRT1-dependent and SIRT1-independent manners. Oxidat Med Cell Longev 2015; 617919; PMID:26583059; https://doi.org/10.1155/2015/617919
   Web of Science ®Google Scholar
• Wang F, Liu H, Blanton WP, Belkina A, Lebrasseur NK, Denis GV. Brd2 disruption in mice causes severe obesity without Type 2 diabetes. Biochem J 2010; 425:71-83; PMID:19883376; https://doi.org/10.1042/BJ20090928
   Web of Science ®Google Scholar
• Wang F, Deeney JT, Denis GV. Brd2 gene disruption causes “metabolically healthy” obesity: epigenetic and chromatin-based mechanisms that uncouple obesity from type 2 diabetes. Vitam Horm 2013; 91:49-75; PMID:23374712; https://doi.org/10.1016/B978-0-12-407766-9.00003-1
   PubMed Web of Science ®Google Scholar
• Liu X, Chen Z, Xu C, Leng X, Cao H, Ouyang G, Xiao W. Repression of hypoxia-inducible factor alpha signaling by Set7-mediated methylation. Nucl Acid Res 2015; 43:5081-98; PMID:25897119; https://doi.org/10.1093/nar/gkv379
   PubMed Web of Science ®Google Scholar
• Rodriguez H, Rafehi H, Bhave M, El-Osta A. Metabolism and chromatin dynamics in health and disease. Mol Aspect Med 2016; PMID:27697603; https://doi.org/10.1016/j.mam.2016.09.004
   PubMed Web of Science ®Google Scholar
• Barsyte-Lovejoy D, Li F, Oudhoff MJ, Tatlock JH, Dong A, Zeng H, Wu H, Freeman SA, Schapira M, Senisterra GA, et al. (R)-PFI-2 is a potent and selective inhibitor of SETD7 methyltransferase activity in cells. Proc Natl Acad Sci U S A 2014; 111:12853-8; PMID:25136132; https://doi.org/10.1073/pnas.1407358111
   PubMed Web of Science ®Google Scholar
• Han HS, Choi D, Choi S, Koo SH. Roles of protein arginine methyltransferases in the control of glucose metabolism. Endocrinol Metabol 2014; 29:435-40; PMID:25559572; https://doi.org/10.3803/EnM.2014.29.4.435
   PubMedGoogle Scholar
• Deeney JT, Belkina AC, Shirihai OS, Corkey BE, Denis GV. BET Bromodomain Proteins Brd2, Brd3 and Brd4 selectively regulate metabolic pathways in the Pancreatic beta-Cell. PloS One 2016; 11:e0151329; PMID:27008626; https://doi.org/10.1371/journal.pone.0151329
   PubMed Web of Science ®Google Scholar
• Krivega I, Dale RK, Dean A. Role of LDB1 in the transition from chromatin looping to transcription activation. Gen Dev 2014; 28:1278-90; PMID:24874989; https://doi.org/10.1101/gad.239749.114
   PubMed Web of Science ®Google Scholar
• Sunshine HR, Hofrichter J, Eaton WA. Requirement for therapeutic inhibition of sickle haemoglobin gelation. Nature 1978; 275:238-40; PMID:692700; https://doi.org/10.1038/275238a0
   PubMed Web of Science ®Google Scholar
• Xu J, Bauer DE, Kerenyi MA, Vo TD, Hou S, Hsu YJ, Yao H, Trowbridge JJ, Mandel G, Orkin SH. Corepressor-dependent silencing of fetal hemoglobin expression by BCL11A. Proc Natl Acad Sci U S A 2013; 110:6518-23; PMID:23576758; https://doi.org/10.1073/pnas.1303976110
   PubMed Web of Science ®Google Scholar
• Bradner JE, Mak R, Tanguturi SK, Mazitschek R, Haggarty SJ, Ross K, Chang CY, Bosco J, West N, Morse E, et al. Chemical genetic strategy identifies histone deacetylase 1 (HDAC1) and HDAC2 as therapeutic targets in sickle cell disease. Proc Natl Acad Sci U S A 2010; 107:12617-22; PMID:20616024; https://doi.org/10.1073/pnas.1006774107
   PubMed Web of Science ®Google Scholar
• Rank G, Cerruti L, Simpson RJ, Moritz RL, Jane SM, Zhao Q. Identification of a PRMT5-dependent repressor complex linked to silencing of human fetal globin gene expression. Blood 2010; 116:1585-92; PMID:20495075; https://doi.org/10.1182/blood-2009-10-251116
   PubMed Web of Science ®Google Scholar
• Shi L, Cui S, Engel JD, Tanabe O. Lysine-specific demethylase 1 is a therapeutic target for fetal hemoglobin induction. Nature Medicine 2013; 19:291-4; PMID:23416702; https://doi.org/10.1038/nm.3101
   PubMed Web of Science ®Google Scholar
• Krivega I, Byrnes C, de Vasconcellos JF, Lee YT, Kaushal M, Dean A, Miller JL. Inhibition of G9a methyltransferase stimulates fetal hemoglobin production by facilitating LCR/gamma-globin looping. Blood 2015; 126:665-72; PMID:25979948; https://doi.org/10.1182/blood-2015-02-629972
   PubMed Web of Science ®Google Scholar
• Renneville A, Van Galen P, Canver MC, McConkey M, Krill-Burger JM, Dorfman DM, Holson EB, Bernstein BE, Orkin SH, Bauer DE, et al. EHMT1 and EHMT2 inhibition induces fetal hemoglobin expression. Blood 2015; 126:1930-9; PMID:26320100; https://doi.org/10.1182/blood-2015-06-649087
   PubMed Web of Science ®Google Scholar
• Kadoch C, Copeland RA, Keilhack H. PRC2 and SWI/SNF chromatin remodeling complexes in health and disease. Biochemistry 2016; 55:1600-14; PMID:26836503; https://doi.org/10.1021/acs.biochem.5b01191
   PubMed Web of Science ®Google Scholar
• Fedorov O, Castex J, Tallant C, Owen DR, Martin S, Aldeghi M, Monteiro O, Filippakopoulos P, Picaud S, Trzupek JD, et al. Selective targeting of the BRG/PB1 bromodomains impairs embryonic and trophoblast stem cell maintenance. Sci Adv 2015; 1:e1500723; PMID:26702435; https://doi.org/10.1126/sciadv.1500723
   PubMedGoogle Scholar
• Vangamudi B, Paul TA, Shah PK, Kost-Alimova M, Nottebaum L, Shi X, Zhan Y, Leo E, Mahadeshwar HS, Protopopov A, et al. The SMARCA2/4 ATPase domain surpasses the bromodomain as a drug target in SWI/SNF-mutant cancers: insights from cDNA rescue and PFI-3 inhibitor studies. Cancer Res 2015; 75:3865-78; PMID:26139243; https://doi.org/10.1158/0008-5472.CAN-14-3798
   PubMed Web of Science ®Google Scholar
• Gerstenberger BS, Trzupek JD, Tallant C, Fedorov O, Filippakopoulos P, Brennan PE, Fedele V, Martin S, Picaud S, Rogers C, et al. Identification of a Chemical Probe for Family VIII Bromodomains through Optimization of a Fragment Hit. J Med Chem 2016; 59:4800-11; PMID:27115555; https://doi.org/10.1021/acs.jmedchem.6b00012
   PubMed Web of Science ®Google Scholar
• Gonzales-Cope M, Sidoli S, Bhanu NV, Won KJ, Garcia BA. Histone H4 acetylation and the epigenetic reader Brd4 are critical regulators of pluripotency in embryonic stem cells. BMC Genomics 2016; 17:95; PMID:26847871; https://doi.org/10.1186/s12864-016-2414-y
   PubMed Web of Science ®Google Scholar
• Hofstetter C, Kampka JM, Huppertz S, Weber H, Schlosser A, Müller AM, Becker M. Inhibition of KDM6 activity during murine ESC differentiation induces DNA damage. J Cell Sc 2016; 129:788-803; PMID:26759175; https://doi.org/10.1242/jcs.175174
   PubMed Web of Science ®Google Scholar
• Kamikawa YF, Donohoe ME. Histone demethylation maintains Prdm14 and Tsix expression and represses xIst in embryonic stem cells. Plos One 2015; 10:e0125626; PMID:25993097; https://doi.org/10.1371/journal.pone.0125626
   PubMed Web of Science ®Google Scholar
• Kang SC, Kim SK, Chai JC, Kim SH, Won KJ, Lee YS, Jung KH, Chai YG. Transcriptomic Profiling and H3K27me3 distribution reveal both Demethylase-Dependent and independent regulation of developmental gene transcription in cell differentiation. Plos One 2015; 10:e0135276; PMID:26263556; https://doi.org/10.1371/journal.pone.0135276
   PubMed Web of Science ®Google Scholar
• Korb E, Herre M, Zucker-Scharff I, Darnell RB, Allis CD. BET protein Brd4 activates transcription in neurons and BET inhibitor Jq1 blocks memory in mice. Nat Neurosci 2015; 18:1464-73; PMID:26301327; https://doi.org/10.1038/nn.4095
   PubMed Web of Science ®Google Scholar
• Xu Y, Cao W, Zhou M, Li C, Luo Y, Wang H, Zhao R, Jiang S, Yang J, Liu Y, et al. Inactivation of BRD7 results in impaired cognitive behavior and reduced synaptic plasticity of the medial prefrontal cortex. Behav Brain Res 2015; 286:1-10; PMID:25721744; https://doi.org/10.1016/j.bbr.2015.02.031
   PubMed Web of Science ®Google Scholar